Vertical Guide

MedTech Lead Generation & SDR Strategy.

How to navigate Value Analysis Committees, clinical buyers, and FDA constraints to build qualified pipeline for medical device companies.

Major Takeaways

$432B+

Global MedTech market size in 2026, growing at ~5.5% CAGR.

6–18 months

Typical MedTech sales cycle from first contact to close.

5–16

Decision-makers on a MedTech buying committee, including clinical and procurement.

VAC

Value Analysis Committees evaluate every device on cost, outcome, and risk.

FDA

Regulatory clearance (510(k) or PMA) shapes what you can say and sell.

7 days

Time to first qualified meeting with a healthcare-specialized SDR team.

Medical technology (MedTech) is one of the most challenging B2B verticals for outbound sales. The buyers are clinicians trained to evaluate evidence. The decisions go through Value Analysis Committees. The messaging is constrained by FDA regulations. And the sales cycles stretch 6 to 18 months — far longer than most B2B technology.

This guide covers how to generate qualified leads and build pipeline in MedTech, including who the real buyers are, how to navigate the VAC process, what content and messaging works, and when it makes sense to outsource your SDR function to a healthcare-specialized partner.

The MedTech Market in 2026

The global MedTech market is valued at over $432 billion in 2026 and growing at approximately 5.5% annually. But the growth is uneven — digital health, diagnostics, and remote monitoring are expanding rapidly, while traditional device categories face pricing pressure from GPOs and value-based care models.

For sales teams, the opportunity is significant but the barriers to entry are high. The companies that win are the ones that can:

Identify the right accounts — hospitals and health systems actively investing in their technology category.

Reach the clinical champions who influence purchasing decisions, not just procurement.

Present clinical evidence that survives VAC scrutiny.

Navigate GPO contracts and pricing frameworks without leaving money on the table.

Who Buys MedTech?

There is no single decision-maker in MedTech. A typical device purchase involves a Value Analysis Committee (VAC) of 5 to 16 people, each with different priorities:

Lead Clinician / Physician

Clinical outcomes, patient safety, ease of use

Department Director

Operational efficiency, staff workflow, budget impact

Supply Chain Manager

Cost, vendor consolidation, GPO alignment

CFO / Finance

ROI, total cost of ownership, reimbursement

Infection Control

Sterilization, cross-contamination risk (if applicable)

IT / Biomedical Engineering

Integration, maintenance, technical support

The key insight: your SDR doesn't need to reach all of them. They need to find the clinical champion — the physician or department leader who feels the pain your product solves — and arm them with the evidence to advocate internally.

Key Sales Challenges

FDA-Compliant Messaging

Your SDRs can't make claims that aren't cleared by the FDA. A 510(k) clearance limits what you can say about indications for use. SDRs need to understand these boundaries — or you risk regulatory exposure that can kill deals and trigger audits.

The VAC Bottleneck

Even when a clinical champion wants your product, the Value Analysis Committee can block it. VACs meet on fixed schedules (often monthly or quarterly), evaluate purchases on cost, clinical outcome, and risk, and require formal presentations with evidence. Missing a VAC cycle can add months to a deal.

GPO Contracts

If your target account buys through a GPO, your pricing and contract terms are constrained by the GPO agreement. SDRs need to understand whether the account is on your GPO contract, whether a conversion is possible, and how to position pricing within that framework.

Clinical Evidence Requirements

Clinicians are trained to evaluate peer-reviewed evidence. A brochure won't earn a VAC presentation. You need published studies, outcome data, and case studies from peer institutions — and your SDRs need to reference them credibly in outreach.

MedTech Lead Generation Strategy

A winning MedTech outbound strategy combines account-based targeting, evidence-led messaging, and omnichannel persistence:

Target by Buying Signals

Use intent data to identify hospitals and health systems actively researching your product category. Look for web visits to clinical content, conference attendance, grant announcements, and capital expenditure reports. Prioritize accounts showing in-market behavior over cold lists.

Find the Clinical Champion

Don't start with procurement — start with the physician or department director who feels the clinical pain your product addresses. Use LinkedIn, clinical directories, and hospital org charts to identify the right person, then craft outreach that references their specific clinical priorities.

Lead with Evidence

Every outreach should reference clinical evidence — a published study, an outcome benchmark, or a case study from a peer institution. SDRs should sound like clinical resources, not salespeople. This builds the credibility needed to earn a VAC presentation.

Run an Omnichannel Cadence

MedTech buyers need 12 to 20 touchpoints to convert. Run coordinated sequences across email, phone, and LinkedIn, with each touch building on the last. Share a different piece of evidence or insight in each touch — not the same pitch on repeat.

Equip the Champion

Once you have a clinical champion, arm them with everything they need to advocate internally: a one-page clinical summary, a cost-benefit analysis, peer references, and answers to common VAC questions. The champion does the internal selling — your job is to make them successful.

When to Outsource MedTech SDRs

Building an in-house MedTech SDR team is expensive and slow. You need reps who understand clinical workflows, FDA constraints, and VAC processes — and training a generalist to that level takes 3 to 6 months. Meanwhile, the fully loaded cost of one in-house SDR reaches $125,000 to $200,000+ per year.

Outsourcing to a healthcare-specialized partner makes sense when:

You need pipeline fast and can't wait 3 to 6 months to hire and ramp.

Your SDRs are spending more time learning the industry than booking meetings.

You lack the clinical evidence library and content needed for credible outreach.

You want to test a new clinical specialty or market segment without a long-term commitment.

You're tired of SDR turnover destroying ramp investments.

A managed MedTech SDR team brings pre-trained reps who understand clinical buyers, a tech stack with intent data and contact verification, and CRM infrastructure optimized for the VAC process. To see what that looks like in practice, explore our client results or learn more about why managed SDR services outperform in-house teams.

FAQs

Frequently Asked Questions

What is MedTech lead generation?

MedTech lead generation is the process of identifying, engaging, and qualifying potential buyers of medical technology products — including devices, diagnostics, and equipment — sold to hospitals, health systems, clinics, and group purchasing organizations (GPOs). It requires navigating Value Analysis Committees, FDA-cleared messaging, and multi-stakeholder buying committees.

How long does it take to sell a medical device?

MedTech sales cycles typically run 6 to 18 months from first contact to close. The length is driven by the Value Analysis Committee (VAC) process, clinical evaluation requirements, FDA regulatory considerations, budget cycles, and the number of stakeholders involved — which can range from 5 to 16 people across clinical, procurement, finance, and IT functions.

Who is the decision-maker for MedTech purchases?

There is rarely a single decision-maker in MedTech. Purchasing decisions go through a Value Analysis Committee that includes the lead clinician or physician, department director, supply chain manager, CFO or finance lead, and sometimes infection control or IT. The key is mapping the entire committee and equipping your clinical champion with the evidence they need to advocate internally.

Can you outsource MedTech SDR and lead generation?

Yes. Outsourcing MedTech lead generation to a healthcare-specialized partner gives you access to SDRs who already understand clinical workflows, VAC processes, and regulatory constraints — without the 3-6 month ramp of training a generalist. A managed team can start booking qualified meetings in as little as 7 days, with the tech stack, data, and coaching already built in.

What content works best for MedTech lead generation?

MedTech buyers respond to clinical evidence above all else. The most effective content includes peer-reviewed studies, outcome data, cost-benefit analyses, case studies from similar institutions, and comparison guides. Thought leadership that helps clinicians do their jobs better — rather than product brochures — builds the trust needed to earn a VAC presentation.

How do GPOs affect MedTech sales?

Group Purchasing Organizations (GPOs) negotiate vendor contracts and pricing on behalf of networks of healthcare providers. If your target account buys through a GPO, you need to understand the existing contract terms, whether your product is on the GPO's approved list, and how to position your pricing within that framework. GPO relationships can accelerate or block a deal.

How do MedTech companies generate leads with hospitals?

MedTech companies generate leads by identifying hospitals actively investing in their category, reaching the clinical champion who feels the pain, and leading with clinical evidence. Outreach runs across email, phone, and LinkedIn, and the champion is equipped with the evidence needed to advocate through the Value Analysis Committee.

Who is on a hospital value analysis committee?

A hospital Value Analysis Committee typically includes the lead clinician or physician, the department director, supply chain, finance, and — depending on the product — infection control and IT/biomedical engineering. Your SDR's job is to find the clinical champion and arm them with the evidence the committee will ask for.

How long does MedTech sales outreach take to produce meetings?

MedTech buyers need 12 to 20 touchpoints to convert, and the full sales cycle runs 6 to 18 months. A healthcare-specialized SDR team can book the first qualified meeting in as little as 7 days, then sustain the cadence through the VAC and procurement stages.

Should MedTech startups outsource SDRs?

Often, yes. Building an in-house MedTech SDR team takes 3 to 6 months to ramp and costs $125,000–$200,000+ per rep per year. Outsourcing to a healthcare-specialized partner gives you pre-trained reps who understand clinical buyers and the VAC process — with the tech stack, data, and coaching included.

Keep exploring

More from Connexu.

Explore the platform

The AI SDR Co-Pilot and managed SDR teams behind these results.

Managed vs. in-house

Why a managed SDR engine costs a fraction of building it yourself.

Client results

$32.1M+ in pipeline generated in 2026 and 1,663 meetings across healthcare clients.

HIPAA-compliant SDR outreach

How to run healthcare outreach that's both compliant and effective.

Selling to health system CMOs

What actually gets a CMO to reply — and what gets archived.

MedTech go-to-market playbook

From FDA clearance to first meetings in 90 days.

Build your MedTech pipeline.

Connexu's healthcare-specialized SDRs understand clinical buyers, VAC processes, and the evidence-based selling that closes medical device deals.

Book a demo